Percutaneous Coronary Intervention Clinical Trials Percutaneous Coronary Intervention RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention
Conditions:   Percutaneous Coronary Intervention;   Coronary Heart Disease;   Robotic Surgical Procedures Intervention:   Device: ALLVAS® robotic-assisted PCI Sponsor:   Shanghai Operation Robot Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials

Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study
Condition:   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Prasugrel Sponsors:   Germano Di Sciascio;   Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium;   Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy;   CardioRISC, C-TRIC, Derry/Londonderry, Northern Ireland, UK;   Department of Cardiology, Lausanne University Center Hospi tal, Lausanne, Switzerland Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2022 Category: Research Source Type: clinical trials